WGND
By
WGND
Published: Oct. 31, 2022, 8:54 p.m.·
Tags:
Medicines,
Research and development
The Stop TB Partnership Working Group on New Drugs (WGND)’ Annual Meeting will take place virtually on 3 November 2022.
Read More →
By
WGND
Published: March 31, 2022, 4:45 p.m.·
Tags:
Drug-resistant TB,
Treatment
Episode 5 of the podcast series, The Dose, by the Stop TB Partnership's Working Group on New TB Drugs (WGND) is now available online. Shobha Shukla speaks with two experts on highly drug-resistant TB, Dr. Francesca Conradie and Dr. Gustavo Velásquez, on the results from ZeNix, a Phase 3 clinical trial exploring potential optimization of a regimen for treating patients with highly drug-resistant TB.
Read More →
By
WGND
Published: July 26, 2021, 3:44 p.m.·
Tags:
Research and development,
Treatment
Episode 4 of the podcast series, The Dose, by the Stop TB Partnership's Working Group on New TB Drugs (WGND) is now available online. Shobha Shukla speaks with TB regimen development experts Dr. Debra Hanna and Dr. Robert Bates on the topic of the PAN-TB collaboration and novel regimen development.
Read More →
By
WGND
Published: Jan. 7, 2019, 3:17 p.m.·
Tags:
Global TB response,
Advocacy
The Stop TB Partnership's Working Group on New TB Drugs (WGND) has released the latest episode of ‘The Dose’ podcast. It focuses on the first-ever UN High-Level Meeting on TB (UN HLM) held in September 2018 and the commitments made there to fight TB.
Read More →
By
WGND
Published: Nov. 20, 2018, 6:41 p.m.·
Tags:
Advocacy,
Research and development
To support community engagement, the Stop TB Partnership's Working Group on New TB Drugs (WGND) will provide a one-year grant to support small scale community initiatives that will enhance and increase community engagement and input into TB drug research & development (R&D).
Read More →
Page 1 of 1 · Total posts: 5
1